Author:
Einhorn Lawrence H.,Brames Mary J.,Dreicer Robert,Nichols Craig R.,Cullen Michael T.,Bubalo Joseph
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Aapro M, Grunberg S, Manikhas G, Olivares G, Suarez T, Tjulandin S, Bertoli L, Yunus F, Morrica B, Lordick F, Macciocchi A (2006) A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 17:1441–1449
2. Baltzer L, Pisters KMW, Kris MG et al (1993) High-dose ondansetron plus dexamethasone for the prevention of nausea and vomiting with multiple-day cisplatin chemotherapy [abstract]. J Clin Oncol 12:462 (Abstract 1607)
3. Cartmell A, Ferguson S, Yanagihara R et al (2003) Protection against chemotherapy-induced nausea and vomiting (CINV) is maintained over multiple cycles of moderately or highly emetogenic chemotherapy by palonosetron (PALO), a potent 5-HT3 receptor antagonist (RA) [abstract and poster]. Proc Am Soc Clin Oncol 22:756 (Abstract 3041)
4. De Mulder PH, Seynaeve C, Vermorken JB, van Liessum PA, Mols-Jevdevic S, Allman EL, Beranek P, Verweij J (1990) Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. Ann Intern Med 113:834–840
5. De Mulder PHM, Roila F, Kris MG, Marty MM (1998) Consensus regarding multiple day and rescue antiemetic therapy. Support Care Cancer 6:248–252
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献